Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Outpatient Discharge Therapy With Saxagliptin+MetforminXR vs GlipizideXL for Type 2 Diabetes With Severe Hyperglycemia

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2010 by John H. Stroger Hospital.
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
Bristol-Myers Squibb
Information provided by:
John H. Stroger Hospital
ClinicalTrials.gov Identifier:
NCT01267448
First received: December 27, 2010
Last updated: April 15, 2011
Last verified: December 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2012
  Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)